comprehensive -WSS

comprehensive

author：comprehensive 2025-09-02 22:03:36 - browse：42

Alex Hogan/STAT

The J.P. Morgan Healthcare Conference is upon us, bringing its frenetic meetings, crowded hallways, and hotel rooms so expensive that even the pharmaceutical industry complains about what a free market does to the prices of scarce goods.

This year’s iteration, starting Monday in San Francisco, finds the biotech industry, in particular, in a curious spot. After a volatile 2023 that saw biotech stocks hit five-year lows in the fall, the sector had a bull run in the final weeks of the year, spurred by some high-dollar merger agreements and a prevailing sense that the macroeconomic winds were finally shifting in biotech’s direction.

Meanwhile, companies selling digital health services like telemedicine, health plans for virtual care, and AI tools for payers face a crucial year as they scramble to make good on profitability projections. Those companies, along with the country’s most powerful health systems, are seriously exploring AI, even ChatGPT, to help them meet financial milestones.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： FDA approves potent Eli Lilly obesity drug, Zepbound

Wikipedia

WSS

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

How to save PrEP access — and even expand it

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Senate panel clears PBM, hopsital reforms

hotspot

comprehensive

hotspot

Drug repurposing or repositioning? The language matters

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

At least 13 dead in Texas as scorching temps continue

Wildfire smoke exposes gaps in outdoor worker protections

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

10 million people disenrolled from Medicaid over past six months

Walensky prepares to leave CDC — and Congress — behind

Just how powerful is the placebo effect?

23andMe had bad news about my health. I wish a person had delivered it

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

explore

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Medicare solvency divides Republicans at the presidential debate

Drug repurposing or repositioning? The language matters

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Sanofi CEO defends move to abandon profit guidance, boost research

Jerome Adams on the need for new antivirals for Covid

hotspot

hotspot

Wikipedia

focus